Clinical experts are using magnetic resonance imaging (MRI) and positron emission tomography (PET) neuroimaging, neuronal injury, amyloid and tau biomarkers, cerebrospinal fluid, and degeneration [5,6,7] for AD diagnosis. The gene discussed is MAPT; the disease is Alzheimer disease.